108,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

This title includes a number of Open Access chapters. Sarcopenia-the loss of muscle mass and strength that occurs with advancing age-is a major health challenge, particularly in North America, Europe, and Japan, which have large aging populations. This compendium volume is a valuable addition to the existing literature, providing state-of-the-art information on the most effective prevention and treatment options. Included are research articles on nutrition management and the prevention of sarcopenia; protein therapy for sarcopenia; effect of exercise on sarcopenia; and other therapeutic strategies, including antioxidants and steroids.…mehr

Produktbeschreibung
This title includes a number of Open Access chapters. Sarcopenia-the loss of muscle mass and strength that occurs with advancing age-is a major health challenge, particularly in North America, Europe, and Japan, which have large aging populations. This compendium volume is a valuable addition to the existing literature, providing state-of-the-art information on the most effective prevention and treatment options. Included are research articles on nutrition management and the prevention of sarcopenia; protein therapy for sarcopenia; effect of exercise on sarcopenia; and other therapeutic strategies, including antioxidants and steroids.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Chad L. Cox is a Lecturer in the Department of Chemistry and the Department of Family and Consumer Sciences at California State University, Sacramento. He also teaches at Sacramento City College and the University of California, Davis. He holds a PhD in Nutritional Biology, a Bachelor of Science in Exercise Biology, and a Bachelor of Science in Nutrition Science, all from UC Davis. His research interests include the causes of obesity and obesity-related chronic diseases, how exercise training can induce changes in the regulation of gene expression that can lead to improvements in insulin sensitivity and promote energy balance, and the development of pharmacological agents that could help reduce the epidemic of obesity, Type 2 diabetes, and metabolic syndrome.